tiprankstipranks
Company Announcements

Matinas BioPharma Slashes Workforce Amid Financial Turmoil

Matinas BioPharma Slashes Workforce Amid Financial Turmoil

Matinas BioPharma ( (MTNB) ) has issued an update.

Matinas BioPharma Holdings has announced an 80% workforce reduction and halted its product development activities as a strategic move to conserve cash following the termination of partnership negotiations for its MAT2203 product. The company is considering options such as a potential asset sale or even dissolving the company itself. This drastic measure comes as Matinas seeks to navigate significant financial challenges and uncertainties in the biotech industry.

For detailed information about MTNB stock, go to TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App